Neptune Technologies & Bioresources Inc Press Releases

NEPT 
$2.51
*  
0.01
0.4%
Get NEPT Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading NEPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Neptune to Hold Conference Call to Discuss First Quarter Results
7/8/2014 8:00:00 AM - GlobeNewswire

Neptune Receives Composition Patent in Australia
6/23/2014 7:00:00 AM - GlobeNewswire

NeuroBioPharm Reports Results of Annual General Meeting
6/20/2014 9:46:00 AM - GlobeNewswire

Neptune Reports Results of Annual and Special Meeting
6/20/2014 9:44:00 AM - GlobeNewswire

Neptune Sherbrooke Plant to Resume Production
6/13/2014 8:00:00 AM - GlobeNewswire

Neptune, Acasti and NeuroBioPharm Announce Litigation Regarding its Former Chief Executive Officer
5/30/2014 8:00:00 AM - Market Wire

Neptune, Acasti and NeuroBioPharm Announce Appointment of Interim CEO
5/23/2014 8:00:00 AM - GlobeNewswire

Neptune Announces Fourth Quarter and Fiscal Year Results
5/21/2014 5:27:00 PM - GlobeNewswire

NeuroBioPharm Announces Resignation of Chief Financial Officer
5/20/2014 8:00:00 AM - GlobeNewswire

Neptune Announces Proposed Director Nominees for Its Upcoming Annual General Meeting
5/16/2014 1:06:00 PM - GlobeNewswire

Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year Results
5/13/2014 8:00:00 AM - GlobeNewswire

Neptune Receives CSST Report
5/8/2014 10:52:00 AM - GlobeNewswire

Photo Release -- Neptune Provides Update on Plant Operating Permits
5/8/2014 8:00:00 AM - GlobeNewswire

Enzymotec Ltd. Announces Signing of Final Settlement and License Agreement With Neptune
4/28/2014 8:46:00 AM - GlobeNewswire

Neptune, Acasti and NeuroBioPharm Announce Resignation of Chief Executive Officer
4/28/2014 8:00:00 AM - GlobeNewswire

Neptune and Enzymotec Conclude Final Patent Infringement Settlement ad License Agreement
4/27/2014 8:32:00 PM - GlobeNewswire

Neptune Obtains New US Patent Relating to Treatment of Alzheimer's
4/24/2014 12:11:00 PM - GlobeNewswire

Neptune Responds to Enzymotec's Continuous Attempts to Shift Focus From ITC Investigation
4/21/2014 1:59:00 PM - GlobeNewswire

Enzymotec Ltd. Announces a Final Decision Issued by the USPTO Rejecting All the Claims in Neptune's Patent
4/21/2014 8:00:00 AM - GlobeNewswire

Iroquois Capital Comments On Recent Schedule 13D Filing On Neptune Technologies & Bioresources Inc.
4/17/2014 8:39:00 AM - PR Newswire